IPO Analysis of Om Megashree Pharmaceuticals Ltd

We have information on the IPO Analysis of Om Megashree Pharmaceuticals Ltd

IPO Analysis of Om Megashree Pharmaceuticals Ltd

Following are the information on the IPO Analysis of Om Megashree Pharmaceuticals Ltd.

About the Company

Om Megashree Pharmaceuticals Ltd is a public limited company, incorporated on June 12, 2016, promoted by group of institutional and individual promoters of Nepal for manufacturing pharmaceuticals products at a plant located in Chitwan, Nepal. The company commenced partial operations from February 19, 2024.

About IPO

The company’s capital is Rs. 60 Crores after IPO, of which 30%, i.e., 18,00,000 unit shares worth Rs. 18 Crores will be issued for the general public. Of this public issue, 10% of the shares, totaling 1,80,000 unit shares, have been allocated for Nepalese citizens working abroad. Out of the total 18,00,000 units, 90,000 (i.e. 5% of 18,00,000) have been set aside for mutual funds and 54,000 (i.e. 3% of 18,00,000) units have been set aside for the employees of the company. The remaining 14,76,000 units are for the general public

ParticularsPercentageNumber of Units
Nepalese citizens working abroad10%1,80,000
Mutual funds5%90,000
Employees of the company3%54,000
General Public82%14,76,000

Prabhu Capital Limited is the issue manager for issuing the IPO to the general public, Nepalese citizens working abroad, mutual funds and employees of the company.

General public, Nepalese citizens working abroad, mutual funds and employees of the company can apply for minimum 10 units and the maximum quantity is 10,000 units.

CARE Rating

CARE Ratings Nepal Limited (CRNL) has reaffirmed the rating of ‘CARE-NP BB- (Is)’ assigned to Om Megashree Pharmaceuticals Limited (OMPL). Issuers with this rating are considered to offer moderate risk of default regarding timely servicing of financial obligations, in Nepal.

Capital Structure

Following is the capital structure of Om Megashree Pharmaceuticals:

CapitalAmount
Authorized CapitalRs. 60,00,00,000
Issued CapitalRs. 60,00,00,000
Current Paid-Up CapitalRs. 42,00,00,000
Capital after IPO IssuanceRs. 18,00,00,000
Low Capital Commercial Banks in Nepal.Low Capital Hydropower Companies in Nepal.
Low Capital Development Banks in Nepal.Low Capital Microfinance Companies in NEPSE.
Low Capital Finance Companies in Nepal.20+ Low Capital Stock in Nepal.

Highlights of Financial statement

Following are the highlights of financial statement of last 3 years from financial statement.

Particulars2077/782078/792079/80
Total Paid-Up Capital (‘000)2,00,0002,00,0004,20,000
Reserve & Surplus (‘000)61,717.28662,249.42262,423.583
Net Profit (‘000)(6,078.347)(10,094.703)13,872.179
Earnings per share (Rs.)-3.04-5.053.3
Net worth per share (Rs.)108.85104.07105.03
Return on Equity (%)  -2.43%-2.82%3.14%

hence, these are the IPO Analysis of Om Megashree Pharmaceuticals.

5+ Blue Chip Companies to invest in Nepal.Top 10 Best Commercial Banks in Nepal.
Low Capital Hydropower Companies in Nepal.EPS of Microfinance Companies in Nepal.
20+ Low Capital Stock in Nepal.EPS of Development Banks in Nepal.

Leave a Comment